🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted steps to address household expense issues" in the upcoming Budget.

During an interview with the BBC, she stated that reducing price rises is a shared responsibility of both the government and the central bank.

The UK's price growth is expected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Possible Utility Cost Measures

It is understood the government could take action to bring down utility costs, for instance by reducing the current 5% rate of value-added tax charged on energy.

A further option is to cut some of the government charges currently added to bills.

Budgetary Limitations and Analyst Predictions

The administration will receive the latest report from the official forecaster, the OBR, on Monday, which will clarify how much space there is for these actions.

The expectation from most analysts is that the Chancellor will have to declare higher taxes or expenditure reductions in order to fulfill her voluntary debt limits.

Previously on Thursday, analysis showed there was a £22 billion shortfall for the chancellor to resolve, which is at the lower end of projections.

"It is a collective responsibility between the central bank and the government to continue tackling some of the causes of price increases," Reeves told reporters in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While a great deal of the attention has been on expected tax increases, the Treasury chief said the latest information from the OBR had not changed her commitment to campaign commitments not to increase rates on income tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with increasing international and trade issues for the fiscal revenue measures, probably to be focused on those "wealthiest."

International Economic Disputes

Addressing apprehensions about the UK's trade ties with the Asian nation she said: "Our national security invariably come first."

Recent declaration by Chinese authorities to increase trade restrictions on critical minerals and other materials that are crucial for high-technology manufacturing led US President the US President to propose an additional 100% import tax on imports from the Asian country, increasing the risk of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary labeled China's decision "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the American proposal to join its battle with China, the Chancellor said she was "very concerned" by Chinese measures and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "harmful for the global economy and generates additional challenges."

"In my view there are fields where we must challenge Chinese policies, but there are also important opportunities to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that balance appropriate."

The chancellor also confirmed she was cooperating with international partners "regarding our own essential resources plan, so that we are more independent."

NHS Drug Pricing and Funding

The Chancellor also acknowledged that the price the NHS spends on pharmaceuticals could rise as a result of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest drug companies have said lately that they are either delaying or abandoning operations in the United Kingdom, with some attributing the modest returns they are getting.

Last month, the government science advisor said the cost the health service spends on drugs would have to rise to prevent companies and drug research funding leaving the UK.

Reeves told the BBC: "We have seen due to the cost structure, that medical research, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other EU nations."

"The objective is to make sure that patients receiving care from the National Health Service are able to obtain the best critical medicines in the world. And so we are reviewing all of that, and... seeking to attract more investment into the UK."